Heparin reversal with protamine sulfate after Percutaneous Hepatic Perfusion (PHP): is less more?

Cancer Imaging

Table 3 Overview of thromboembolic (CTCAE grade 1-5) adverse events

Group	Adverse event	Area	Days after PHP	treatment	sequalae	n
group_PRO	Ischemic stroke	MCA	1^st	none	none	1
group_PRO	Ischemic stroke	Bilateral PCA	4^th	none	none	1
group_PRO	Ischemic stroke	PCA	6^th	none	none	1
group_PRO	Ischemic stroke	PCA	5^th	none	none	1
group_PRO	Ischemic stroke; PE; DVT	Basilar artery (stroke)	2^nd	Thrombectomy, anticoagulation	none	1
group_PRO	Ischemic stroke	MCA and ACA	1^st	Thrombectomy, anticoagulation	death	1
group_PRO	Ischemic stroke	MCA (and ACA)	1^st	Thrombectomy, anticoagulation	yes	1
group_PRO	NSTEMI	LAD	1^st	PTCA	none	1
group_PRO	DVT	Femoral and popliteal vein	1^st week	Anticoagulation	none	1
group_PRO	PE	Central pulmonary arteries	2^nd	Anticoagulation	none	1

Day of the PHP procedure = 1^st day
CTCAE Common Terminology Criteria for Adverse Events, PHP Percutaneous hepatic perfusion, MCA Middle cerebral artery, PCA Posterior cerebral artery, ACA Anterior cerebral artery, NSTEMI Non-ST-segment elevation myocardial infarction, LAD Left anterior descending artery, PTCA Percutaneous transluminal coronary angioplasty, DVT Deep vein thrombosis, PE Pulmonary embolism

ISSN: 1470-7330